Histone Deacetylase Inhibitor Treatment Increases the Expression of the Plasma Membrane Ca(2+) Pump PMCA4b and Inhibits the Migration of Melanoma Cells Independent of ERK

Several new therapeutic options emerged recently to treat metastatic melanoma; however, the high frequency of intrinsic and acquired resistance among patients shows a need for new therapeutic options. Previously, we identified the plasma membrane Ca(2+) ATPase 4b (PMCA4b) as a metastasis suppressor...

Descripción completa

Detalles Bibliográficos
Autores principales: Hegedüs, Luca, Padányi, Rita, Molnár, Judit, Pászty, Katalin, Varga, Karolina, Kenessey, István, Sárközy, Eszter, Wolf, Matthias, Grusch, Michael, Hegyi, Zoltán, Homolya, László, Aigner, Clemens, Garay, Tamás, Hegedüs, Balázs, Tímár, József, Kállay, Enikö, Enyedi, Ágnes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442207/
https://www.ncbi.nlm.nih.gov/pubmed/28596940
http://dx.doi.org/10.3389/fonc.2017.00095

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442207/
https://www.ncbi.nlm.nih.gov/pubmed/28596940
http://dx.doi.org/10.3389/fonc.2017.00095

Ejemplares similares